Khaing M, U N, Maw L, Arkar H, Naing S, Thet M
Infect Dis Poverty. 2024; 13(1):81.
PMID: 39497185
PMC: 11536886.
DOI: 10.1186/s40249-024-01248-7.
Ciobanu A, Plesca V, Doltu S, Manea M, Domente L, Dadu A
IJTLD Open. 2024; 1(6):266-273.
PMID: 39021450
PMC: 11249656.
DOI: 10.5588/ijtldopen.23.0608.
Ciobanu A, Plesca V, Doltu S, Manea M, Domente L, Dadu A
IJTLD Open. 2024; 1(4):181-188.
PMID: 38988411
PMC: 11231822.
DOI: 10.5588/ijtldopen.23.0607.
Bio R, Akweongo P, Koduah A, Adomah-Afari A
BMC Health Serv Res. 2024; 24(1):148.
PMID: 38291448
PMC: 10826066.
DOI: 10.1186/s12913-024-10611-1.
Sinha R, Rana R, Kujur A, Jahnavi G, Kumar M, Venugopal V
Cureus. 2023; 15(10):e47296.
PMID: 38021489
PMC: 10656432.
DOI: 10.7759/cureus.47296.
What matters most? A qualitative study exploring priorities for supportive interventions for people with tuberculosis in urban Viet Nam.
Smith I, Forse R, Annerstedt K, Thanh N, Nguyen L, Phan T
BMJ Open. 2023; 13(8):e076076.
PMID: 37612116
PMC: 10450053.
DOI: 10.1136/bmjopen-2023-076076.
When should we be able to divert the cost of tuberculosis to other diseases?.
Mukhida S, Das N
J Family Med Prim Care. 2023; 12(5):1024-1025.
PMID: 37448917
PMC: 10336946.
DOI: 10.4103/jfmpc.jfmpc_214_23.
Free drug provision for tuberculosis increases patient follow-ups and successful treatment outcomes in the Indian private sector: a quasi experimental study using propensity score matching.
Sodhi R, Penkunas M, Pal A
BMC Infect Dis. 2023; 23(1):421.
PMID: 37344775
PMC: 10283201.
DOI: 10.1186/s12879-023-08396-5.
Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial.
Shete P, Kadota J, Nanyunja G, Namale C, Nalugwa T, Oyuku D
ERJ Open Res. 2023; 9(3).
PMID: 37342088
PMC: 10277874.
DOI: 10.1183/23120541.00182-2023.
Household treatment cost of breast cancer and cost coping strategies from a tertiary facility in Ghana.
Adanu K, Bansah E, Adedia D, Aikins M
PLOS Glob Public Health. 2023; 2(3):e0000268.
PMID: 36962351
PMC: 10022245.
DOI: 10.1371/journal.pgph.0000268.
Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies.
Ghazy R, Sallam M, Ashmawy R, Elzorkany A, Reyad O, Hamdy N
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36768005
PMC: 9915462.
DOI: 10.3390/ijerph20032640.
Assessment of Knowledge, Attitudes, and Practices (KAP): Public Health and Economic Burden of Tuberculosis in Jarso District of West Wollega Zone, Oromia, Western Ethiopia.
Hailu G, Etefa M, Begna F
Biomed Res Int. 2022; 2022:3314725.
PMID: 36531653
PMC: 9754832.
DOI: 10.1155/2022/3314725.
Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania.
Kilale A, Makasi C, Majaha M, Manga C, Haule S, Hilary P
BMC Public Health. 2022; 22(1):2187.
PMID: 36434606
PMC: 9701028.
DOI: 10.1186/s12889-022-14607-6.
Prevalence and Retrospective Insight on Tuberculosis in Human Patients in Cross River State, Nigeria; One Health Approach to its Control.
Bikom P, Nwankwo I, Nwanta J
Curr Microbiol. 2022; 79(11):345.
PMID: 36209340
DOI: 10.1007/s00284-022-03046-6.
Appraisal on patient compliance and factors influencing the daily regimen of anti-tubercular drugs in Mangalore city: A cross-sectional study.
Motappa R, Fathima T, Kotian H
F1000Res. 2022; 11:462.
PMID: 35919097
PMC: 9296992.
DOI: 10.12688/f1000research.109006.2.
Estimating the pre- and post-diagnosis costs of tuberculosis for adults in Pakistan: household economic impact and costs mitigating strategies.
Razzaq S, Zahidie A, Fatmi Z
Glob Health Res Policy. 2022; 7(1):22.
PMID: 35858877
PMC: 9301862.
DOI: 10.1186/s41256-022-00259-x.
Economic evaluation of patient costs associated with tuberculosis diagnosis and care in Solomon Islands.
Viney K, Itogo N, Yamanaka T, Jebeniani R, Hazarika A, Morishita F
BMC Public Health. 2021; 21(1):1928.
PMID: 34688266
PMC: 8542301.
DOI: 10.1186/s12889-021-11938-8.
A Cross-sectional Study on the Magnitude of undernutrition in Tuberculosis Patients in the Oromia Region of Ethiopia.
Hussien B, Ameni G
J Multidiscip Healthc. 2021; 14:2421-2428.
PMID: 34511925
PMC: 8421325.
DOI: 10.2147/JMDH.S326233.
Measuring Catastrophic Costs Due to Tuberculosis in Myanmar.
Aung S, Thu A, Aung H, Thu M
Trop Med Infect Dis. 2021; 6(3).
PMID: 34287379
PMC: 8293353.
DOI: 10.3390/tropicalmed6030130.
Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya.
Kirubi B, Ongango J, Nguhiu P, Lonnroth K, Rono A, Sidney-Annerstedt K
Infect Dis Poverty. 2021; 10(1):95.
PMID: 34225790
PMC: 8256229.
DOI: 10.1186/s40249-021-00879-4.